The effect of intensive treatment of hypertension on cardiovascular events, generalized to middle-aged to older Americans living with hypertension - Summary - MDSpire

The effect of intensive treatment of hypertension on cardiovascular events, generalized to middle-aged to older Americans living with hypertension

  • By

  • Nicola M Shen

  • Amal A Wanigatunga

  • Erin D Michos

  • Walter T Ambrosius

  • Catherine R Lesko

  • December 26, 2024

  • 0 min

Share

Objective:

To generalize the SPRINT trial results to US adults eligible for intensive hypertension treatment and estimate the effect on cardiovascular events.

Key Findings:
  • HR for cardiovascular disease events was 0.76 (95% CI: 0.53, 1.08) for intensive vs standard treatment.
  • 5-year risk difference for cardiovascular events was -2.2% (95% CI: -5.3%, 1.6%).
  • HR for serious adverse events was 0.97 (95% CI: 0.83, 1.13).
Interpretation:

Intensive hypertension management may provide similar benefits in reducing cardiovascular events and adverse events in the broader target population compared to the original SPRINT trial.

Limitations:
  • Differences in demographics and health status between SPRINT participants and the general target population.
  • Potential biases in applying trial results to a broader population.
Conclusion:

The findings suggest that intensive treatment of hypertension can be beneficial for middle-aged and older adults in the US, aligning with SPRINT trial outcomes.

Original Source(s)

Related Content